Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

OBJECTIVE: This study is aimed at investigating whether exenatide (Exe) delays the progression of nonalcoholic fatty liver disease (NAFLD) in C57BL/6 mice by targeting the NLRP3 inflammasome through the autophagy/mitophagy pathway. METHODS: Thirty male C57BL/6 mice were randomly divided into three g...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Ning, Yu, Xin-Yang, Ma, Xue-Fei, Lin, Wen-Jian, Hao, Ming, Kuang, Hong-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925008/
https://www.ncbi.nlm.nih.gov/pubmed/29849583
http://dx.doi.org/10.1155/2018/1864307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925008/
https://www.ncbi.nlm.nih.gov/pubmed/29849583
http://dx.doi.org/10.1155/2018/1864307

Ejemplares similares